Skip to content

Mobile Mindfulness Intervention for Psychological Distress Among Intensive Care Unit Survivors: A Randomized Clinical Trial.

Christopher E Cox, John A Gallis, Maren K Olsen, Laura S Porter, Tina Gremore, Jeffrey M Greeson, Cynthia Morris, Marc Moss, Catherine L Hough

JAMA internal medicine July 1, 2024 DOI: 10.1001/jamainternmed.2024.0823 via PubMed

Summary

AI-generated from the abstract

Among survivors of critical illness with elevated depression symptoms, a mindfulness intervention delivered via a mobile app was tested to find the best way to deliver it. In a randomized trial with 247 participants, those who meditated twice daily had lower depression scores at one month (by 1.2 points on a 27-point scale) and at three months (by 1.5 points) compared to those who meditated once daily. The method of introducing the intervention (app vs. therapist call) and how increasing symptoms were managed (app vs. therapist call) did not affect depression scores. Adherence was high, with 87.9% still using the intervention at the end. The optimal version combined an app-based introduction, twice-daily guided meditation, and app-based symptom management.

Study at a glance

Characteristics Randomized clinical trial Peer reviewed
Sample size 247
Population Survivors of critical illness with elevated postdischarge symptoms of depression
Intervention Mindfulness meditation
Duration 1-month and 3-month follow-up
Citations 22
Registration NCT04038567
Key finding Twice-daily meditation via a mobile app was associated with lower depression scores at one and three months compared to once-daily meditation, while other intervention components showed no main effects.

Abstract

Although psychological distress is common among survivors of critical illness, there are few tailored therapies. To determine the optimal method for delivering a mindfulness intervention via a mobile app for critical illness survivors. This randomized clinical trial used a 2 × 2 × 2 factorial design and was conducted at 3 sites among survivors of critical illness with elevated postdischarge symptoms of depression. The study was conducted between August 2019 and July 2023. Participants were randomized to 1 of 8 different groups as determined by 3 two-level intervention component combinations: intervention introduction method (mobile app vs therapist call), mindfulness meditation dose (once daily vs twice daily), and management of increasing symptoms (mobile app vs therapist call). The primary outcome was the 9-item Patient Health Questionnaire (PHQ-9) depression scale score (range, 0-27) at 1 month. Secondary outcomes included anxiety (7-item Generalized Anxiety Disorder) and posttraumatic stress disorder (Posttraumatic Stress Scale) symptoms at 1 and 3 months, adherence, and feasibility. General linear models were used to compare main effects and interactions of the components among intervention groups. A formal decisional framework was used to determine an optimized intervention version. A total of 247 participants (mean [SD] age, 50.2 [15.4] years; 104 [42.1%] women) were randomized. Twice-daily meditation compared with once-daily meditation was associated with a 1.2 (95% CI, 0.04-2.4)-unit lower mean estimated PHQ-9 score at 1 month and a 1.5 (95% CI, 0.1-2.8)-unit lower estimated mean score at 3 months. The other 2 intervention components had no main effects on the PHQ-9. Across-group adherence was high (217 participants [87.9%] using the intervention at trial conclusion) and retention was strong (191 [77.3%] and 182 [73.7%] at 1 and 3 months, respectively). A mindfulness intervention for survivors of critical illness that included an app-based introduction, twice-daily guided meditation, and app-based management of increasing depression symptoms was optimal considering effects on psychological distress symptoms, adherence, and feasibility. ClinicalTrials.gov Identifier: NCT04038567.

Comments

No comments yet.

Log in to comment